| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.30e-05 | 18 | 211 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | pre-mRNA 3'-splice site binding | 3.95e-05 | 7 | 211 | 3 | GO:0030628 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.12e-04 | 103 | 211 | 7 | GO:0004553 | |
| GeneOntologyMolecularFunction | coreceptor activity | 1.13e-04 | 72 | 211 | 6 | GO:0015026 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.50e-04 | 144 | 211 | 8 | GO:0016798 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.81e-04 | 188 | 211 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.03e-04 | 28 | 211 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 2.39e-04 | 12 | 211 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.83e-04 | 85 | 211 | 6 | GO:0019199 | |
| GeneOntologyMolecularFunction | glucosidase activity | 4.82e-04 | 15 | 211 | 3 | GO:0015926 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 5.76e-04 | 97 | 211 | 6 | GO:0004896 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 6.09e-04 | 37 | 211 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity | 6.58e-04 | 4 | 211 | 2 | GO:0050510 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein-specific endopeptidase activity | 1.09e-03 | 5 | 211 | 2 | GO:0070137 | |
| GeneOntologyMolecularFunction | SUMO-specific endopeptidase activity | 1.09e-03 | 5 | 211 | 2 | GO:0070139 | |
| GeneOntologyMolecularFunction | beta-galactosidase activity | 1.09e-03 | 5 | 211 | 2 | GO:0004565 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 1.09e-03 | 5 | 211 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | L-ascorbic acid binding | 1.16e-03 | 20 | 211 | 3 | GO:0031418 | |
| GeneOntologyBiologicalProcess | disaccharide catabolic process | 4.50e-06 | 4 | 216 | 3 | GO:0046352 | |
| GeneOntologyBiologicalProcess | oligosaccharide catabolic process | 1.93e-05 | 16 | 216 | 4 | GO:0009313 | |
| GeneOntologyCellularComponent | side of membrane | NCAM2 CRLF2 CFHR4 PTPN3 BTN1A1 SCNN1A CCR4 CCR8 GNAL GNAS RECK CNTN1 RNF31 SEMA7A TRGV2 TRGV3 TRGV4 TRGV5 TRGV8 LCT CR2 CD8A CD226 BTN2A3P IL7R | 4.75e-06 | 875 | 217 | 25 | GO:0098552 |
| GeneOntologyCellularComponent | external side of plasma membrane | CRLF2 CFHR4 BTN1A1 SCNN1A CCR4 CCR8 SEMA7A TRGV2 TRGV3 TRGV4 TRGV5 TRGV8 LCT CR2 CD8A CD226 BTN2A3P IL7R | 8.65e-06 | 519 | 217 | 18 | GO:0009897 |
| GeneOntologyCellularComponent | receptor complex | ACVR2B ITGB4 CRLF2 NRP2 PLXNB3 VWC2 RNF31 NTRK3 ROR2 TRGV2 TRGV3 TRGV4 TRGV5 TRGV8 GRIA3 CR2 ARNT CD8A PLXNC1 | 1.11e-05 | 581 | 217 | 19 | GO:0043235 |
| GeneOntologyCellularComponent | cell surface | ITGB4 CRLF2 CFHR4 BTN1A1 SCNN1A PLAT CCR4 CCR8 PLXNB3 CACNA1D DPP4 SEMA7A ROR2 TRGV2 TRGV3 TRGV4 TRGV5 TRGV8 LCT CR2 CD8A TIGIT P2RY1 CD226 BTN2A3P PAM IL7R | 3.55e-05 | 1111 | 217 | 27 | GO:0009986 |
| GeneOntologyCellularComponent | U2AF complex | 3.74e-05 | 7 | 217 | 3 | GO:0089701 | |
| GeneOntologyCellularComponent | basement membrane | 4.14e-05 | 122 | 217 | 8 | GO:0005604 | |
| GeneOntologyCellularComponent | glutamatergic synapse | DLGAP2 ABR ITGB4 TENM2 NRP2 NRXN3 ACAN PLAT NOS1 CNTN1 VWC2 VPS18 ABI1 CAMK2B NTRK3 ROR2 GRIA3 ARRB2 P2RY1 PLXNC1 CADPS2 IL1RAP | 4.46e-05 | 817 | 217 | 22 | GO:0098978 |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.20e-04 | 25 | 217 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | LAMA1 HAPLN4 ZP2 ITGB4 FBN1 P3H1 ACAN PLAT PLOD1 VWC2 MXRA5 VTN SEMA7A EGFL6 PCOLCE2 LTBP1 | 1.41e-04 | 530 | 217 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | postsynapse | DLGAP2 ABR ITGB4 TENM2 NRP2 LIN7B PLAT NOS1 CNTN1 CACNA1E VWC2 ABI1 CAMK2B NTRK3 ROR2 GRIA3 ARRB2 P2RY1 SENP6 MACF1 INSYN2B CADPS2 SENP7 RPL18A | 1.57e-04 | 1018 | 217 | 24 | GO:0098794 |
| GeneOntologyCellularComponent | extracellular matrix | LAMA1 HAPLN4 ZP2 ITGB4 FBN1 OTOGL P3H1 ACAN PLAT PLOD1 VWC2 MXRA5 VTN SEMA7A EGFL6 ADAMTS6 PCOLCE2 LTBP1 | 1.79e-04 | 656 | 217 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMA1 HAPLN4 ZP2 ITGB4 FBN1 OTOGL P3H1 ACAN PLAT PLOD1 VWC2 MXRA5 VTN SEMA7A EGFL6 ADAMTS6 PCOLCE2 LTBP1 | 1.86e-04 | 658 | 217 | 18 | GO:0030312 |
| GeneOntologyCellularComponent | semaphorin receptor complex | 2.92e-04 | 13 | 217 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | ACVR2B HCN2 ITGB4 LIN7B GNAL GNAS CACNA1D CACNA1E VWC2 VTN RNF31 TRGV2 TRGV3 TRGV4 TRGV5 TRGV8 GRIA3 SLCO6A1 CD8A | 5.67e-04 | 785 | 217 | 19 | GO:0098797 |
| GeneOntologyCellularComponent | BRCA1-B complex | 6.35e-04 | 4 | 217 | 2 | GO:0070532 | |
| GeneOntologyCellularComponent | postsynaptic membrane | ITGB4 TENM2 NRP2 LIN7B CNTN1 CACNA1E VWC2 NTRK3 GRIA3 ARRB2 P2RY1 CADPS2 | 1.13e-03 | 405 | 217 | 12 | GO:0045211 |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | ACVR2B ITGB4 VWC2 RNF31 TRGV2 TRGV3 TRGV4 TRGV5 TRGV8 GRIA3 CD8A | 1.13e-03 | 350 | 217 | 11 | GO:0098802 |
| GeneOntologyCellularComponent | synaptic membrane | NCAM2 ITGB4 TENM2 NRP2 LIN7B NRXN3 CNTN1 CACNA1D CACNA1E VWC2 NTRK3 GRIA3 ARRB2 P2RY1 CADPS2 | 1.19e-03 | 583 | 217 | 15 | GO:0097060 |
| Domain | Ig-like_fold | IL10RA PRTG IGFN1 PDGFRL NXPE4 OBSCN HAPLN4 NCAM2 ITGB4 CRLF2 TMEM81 IGSF10 CD101 BTN1A1 PLXNB3 CNTN1 MXRA5 DSCAM SEMA7A NTRK3 ROR2 CD8A TIGIT CD226 PLXNC1 BTN2A3P IL1RAP IL7R SEMA3E MYBPC2 | 2.03e-10 | 706 | 205 | 30 | IPR013783 |
| Domain | - | IL10RA PRTG IGFN1 PDGFRL NXPE4 OBSCN HAPLN4 NCAM2 ITGB4 CRLF2 TMEM81 IGSF10 CD101 BTN1A1 PLXNB3 CNTN1 MXRA5 DSCAM SEMA7A NTRK3 ROR2 CD8A TIGIT CD226 PLXNC1 IL1RAP IL7R SEMA3E MYBPC2 | 2.14e-10 | 663 | 205 | 29 | 2.60.40.10 |
| Domain | IG | PRTG IGFN1 PDGFRL OBSCN HAPLN4 NCAM2 TMEM81 IGSF10 CD101 BTN1A1 CNTN1 MXRA5 DSCAM SEMA7A NTRK3 ROR2 CD8A TIGIT CD226 IL1RAP SEMA3E MYBPC2 | 1.53e-09 | 421 | 205 | 22 | SM00409 |
| Domain | Ig_sub | PRTG IGFN1 PDGFRL OBSCN HAPLN4 NCAM2 TMEM81 IGSF10 CD101 BTN1A1 CNTN1 MXRA5 DSCAM SEMA7A NTRK3 ROR2 CD8A TIGIT CD226 IL1RAP SEMA3E MYBPC2 | 1.53e-09 | 421 | 205 | 22 | IPR003599 |
| Domain | IG_LIKE | PRTG IGFN1 PDGFRL OBSCN HAPLN4 NCAM2 TMEM81 IGSF10 CD101 BTN1A1 CNTN1 MXRA5 DSCAM SEMA7A NTRK3 ROR2 CD8A TIGIT CD226 BTN2A3P IL1RAP SEMA3E MYBPC2 | 5.13e-09 | 491 | 205 | 23 | PS50835 |
| Domain | Ig-like_dom | PRTG IGFN1 PDGFRL OBSCN HAPLN4 NCAM2 TMEM81 IGSF10 CD101 BTN1A1 CNTN1 MXRA5 DSCAM SEMA7A NTRK3 ROR2 CD8A TIGIT CD226 BTN2A3P IL1RAP SEMA3E MYBPC2 | 8.08e-09 | 503 | 205 | 23 | IPR007110 |
| Domain | IGv | 1.30e-07 | 75 | 205 | 9 | SM00406 | |
| Domain | Ig_I-set | PRTG IGFN1 PDGFRL OBSCN NCAM2 IGSF10 CD101 CNTN1 MXRA5 DSCAM NTRK3 ROR2 MYBPC2 | 1.86e-07 | 190 | 205 | 13 | IPR013098 |
| Domain | I-set | PRTG IGFN1 PDGFRL OBSCN NCAM2 IGSF10 CD101 CNTN1 MXRA5 DSCAM NTRK3 ROR2 MYBPC2 | 1.86e-07 | 190 | 205 | 13 | PF07679 |
| Domain | IGc2 | PRTG IGFN1 PDGFRL OBSCN HAPLN4 NCAM2 IGSF10 CNTN1 MXRA5 DSCAM ROR2 CD226 MYBPC2 | 2.07e-06 | 235 | 205 | 13 | SM00408 |
| Domain | Ig_sub2 | PRTG IGFN1 PDGFRL OBSCN HAPLN4 NCAM2 IGSF10 CNTN1 MXRA5 DSCAM ROR2 CD226 MYBPC2 | 2.07e-06 | 235 | 205 | 13 | IPR003598 |
| Domain | PP2Ac | 9.33e-06 | 13 | 205 | 4 | SM00156 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 9.33e-06 | 13 | 205 | 4 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 9.33e-06 | 13 | 205 | 4 | PS00125 | |
| Domain | Ig_V-set | OBSCN HAPLN4 NCAM2 IGSF10 CD101 BTN1A1 DSCAM CD8A TIGIT CD226 BTN2A3P | 1.29e-05 | 199 | 205 | 11 | IPR013106 |
| Domain | FN3_dom | IL10RA PRTG IGFN1 OBSCN NCAM2 ITGB4 CRLF2 CNTN1 DSCAM IL7R MYBPC2 | 2.04e-05 | 209 | 205 | 11 | IPR003961 |
| Domain | Glycoside_hydrolase_SF | 2.43e-05 | 53 | 205 | 6 | IPR017853 | |
| Domain | FN3 | 7.20e-05 | 199 | 205 | 10 | PS50853 | |
| Domain | fn3 | 7.71e-05 | 162 | 205 | 9 | PF00041 | |
| Domain | PSI | 1.16e-04 | 44 | 205 | 5 | IPR016201 | |
| Domain | Gprotein_alpha_S | 1.20e-04 | 2 | 205 | 2 | IPR000367 | |
| Domain | Dihydroorotase_CS | 1.20e-04 | 2 | 205 | 2 | IPR002195 | |
| Domain | PSI | 1.44e-04 | 46 | 205 | 5 | SM00423 | |
| Domain | FN3 | 2.11e-04 | 185 | 205 | 9 | SM00060 | |
| Domain | Metallophos | 2.35e-04 | 28 | 205 | 4 | PF00149 | |
| Domain | Calcineurin-like_PHP_ApaH | 2.35e-04 | 28 | 205 | 4 | IPR004843 | |
| Domain | Metallo-depent_PP-like | 3.09e-04 | 30 | 205 | 4 | IPR029052 | |
| Domain | - | 3.09e-04 | 30 | 205 | 4 | 3.60.21.10 | |
| Domain | Semap_dom | 3.52e-04 | 31 | 205 | 4 | IPR001627 | |
| Domain | SEMA | 3.52e-04 | 31 | 205 | 4 | PS51004 | |
| Domain | Sema | 3.52e-04 | 31 | 205 | 4 | SM00630 | |
| Domain | Sema | 3.52e-04 | 31 | 205 | 4 | PF01403 | |
| Domain | DUF1356_TMEM106 | 3.57e-04 | 3 | 205 | 2 | IPR009790 | |
| Domain | DUF1356 | 3.57e-04 | 3 | 205 | 2 | PF07092 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.34e-04 | 14 | 205 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.34e-04 | 14 | 205 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.34e-04 | 14 | 205 | 3 | IPR013602 | |
| Domain | DHC_N2 | 4.34e-04 | 14 | 205 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.34e-04 | 14 | 205 | 3 | IPR011704 | |
| Domain | MT | 4.34e-04 | 14 | 205 | 3 | PF12777 | |
| Domain | AAA_8 | 4.34e-04 | 14 | 205 | 3 | PF12780 | |
| Domain | AAA_5 | 4.34e-04 | 14 | 205 | 3 | PF07728 | |
| Domain | DHC_fam | 5.38e-04 | 15 | 205 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 5.38e-04 | 15 | 205 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 5.38e-04 | 15 | 205 | 3 | IPR004273 | |
| Domain | - | 5.65e-04 | 35 | 205 | 4 | 3.20.20.80 | |
| Domain | Arrestin_N | 7.09e-04 | 4 | 205 | 2 | IPR014753 | |
| Domain | Glyco_hydro_35 | 7.09e-04 | 4 | 205 | 2 | PF01301 | |
| Domain | Glyco_hydro_31_CS | 7.09e-04 | 4 | 205 | 2 | IPR030459 | |
| Domain | GLYCOSYL_HYDROL_F35 | 7.09e-04 | 4 | 205 | 2 | PS01182 | |
| Domain | Gal_mutarotase_N | 7.09e-04 | 4 | 205 | 2 | IPR031727 | |
| Domain | Arrestin_CS | 7.09e-04 | 4 | 205 | 2 | IPR017864 | |
| Domain | ARRESTINS | 7.09e-04 | 4 | 205 | 2 | PS00295 | |
| Domain | Arrestin | 7.09e-04 | 4 | 205 | 2 | IPR000698 | |
| Domain | - | 7.09e-04 | 4 | 205 | 2 | 2.60.40.840 | |
| Domain | Gly_Hdrlase_35_cat | 7.09e-04 | 4 | 205 | 2 | IPR031330 | |
| Domain | Glycoside_Hdrlase_35 | 7.09e-04 | 4 | 205 | 2 | IPR001944 | |
| Domain | B-gal_1-like | 7.09e-04 | 4 | 205 | 2 | IPR026283 | |
| Domain | NtCtMGAM_N | 7.09e-04 | 4 | 205 | 2 | PF16863 | |
| Domain | Glyco_hydro_catalytic_dom | 7.77e-04 | 38 | 205 | 4 | IPR013781 | |
| Domain | PH | ARHGAP24 ABR OBSCN PLEKHH1 TRIOBP ARAP3 PLEKHG3 PRKD1 CADPS2 | 9.91e-04 | 229 | 205 | 9 | PF00169 |
| Domain | PH | ARHGAP24 ABR OBSCN PLEKHH1 PLCL2 TRIOBP ARAP3 PLEKHG3 PRKD1 CADPS2 | 1.03e-03 | 278 | 205 | 10 | SM00233 |
| Domain | PH_DOMAIN | ARHGAP24 ABR OBSCN PLEKHH1 PLCL2 TRIOBP ARAP3 PLEKHG3 PRKD1 CADPS2 | 1.06e-03 | 279 | 205 | 10 | PS50003 |
| Domain | PH_domain | ARHGAP24 ABR OBSCN PLEKHH1 PLCL2 TRIOBP ARAP3 PLEKHG3 PRKD1 CADPS2 | 1.09e-03 | 280 | 205 | 10 | IPR001849 |
| Domain | BRCT | 1.11e-03 | 19 | 205 | 3 | PF00533 | |
| Domain | U2AF_small | 1.17e-03 | 5 | 205 | 2 | IPR009145 | |
| Domain | GLYCOSYL_HYDROL_F31_2 | 1.17e-03 | 5 | 205 | 2 | PS00707 | |
| Domain | BRCT | 1.72e-03 | 22 | 205 | 3 | SM00292 | |
| Domain | Glyco_hydro_31_AS | 1.75e-03 | 6 | 205 | 2 | IPR030458 | |
| Domain | - | 1.96e-03 | 23 | 205 | 3 | 3.40.50.10190 | |
| Domain | EGF_1 | 2.08e-03 | 255 | 205 | 9 | PS00022 | |
| Domain | Clathrin | 2.43e-03 | 7 | 205 | 2 | PF00637 | |
| Domain | Glyco_hydro_31 | 2.43e-03 | 7 | 205 | 2 | IPR000322 | |
| Domain | TB | 2.43e-03 | 7 | 205 | 2 | PF00683 | |
| Domain | Glyco_hydro_31 | 2.43e-03 | 7 | 205 | 2 | PF01055 | |
| Domain | Ca_chan_IQ | 2.43e-03 | 7 | 205 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 2.43e-03 | 7 | 205 | 2 | PF08763 | |
| Domain | Peptidase_C48_C | 2.43e-03 | 7 | 205 | 2 | IPR003653 | |
| Domain | Peptidase_C48 | 2.43e-03 | 7 | 205 | 2 | PF02902 | |
| Domain | - | 2.43e-03 | 7 | 205 | 2 | 2.60.40.640 | |
| Domain | VDCC_a1su_IQ | 2.43e-03 | 7 | 205 | 2 | IPR014873 | |
| Domain | GPHH | 2.43e-03 | 7 | 205 | 2 | PF16905 | |
| Domain | GPHH_dom | 2.43e-03 | 7 | 205 | 2 | IPR031649 | |
| Domain | CHCR | 2.43e-03 | 7 | 205 | 2 | PS50236 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 2.43e-03 | 7 | 205 | 2 | PS00129 | |
| Domain | ULP_PROTEASE | 2.43e-03 | 7 | 205 | 2 | PS50600 | |
| Domain | EGF-like_CS | 2.43e-03 | 261 | 205 | 9 | IPR013032 | |
| Domain | Sushi | 2.53e-03 | 52 | 205 | 4 | PF00084 | |
| Domain | EGF_2 | 2.69e-03 | 265 | 205 | 9 | PS01186 | |
| Domain | BRCT | 2.81e-03 | 26 | 205 | 3 | PS50172 | |
| Domain | Rho_GTPase_activation_prot | 2.84e-03 | 88 | 205 | 5 | IPR008936 | |
| Domain | CCP | 2.90e-03 | 54 | 205 | 4 | SM00032 | |
| Domain | TUDOR | 3.14e-03 | 27 | 205 | 3 | SM00333 | |
| Domain | Arrestin_C | 3.21e-03 | 8 | 205 | 2 | IPR014752 | |
| Domain | Clathrin_H-chain/VPS_repeat | 3.21e-03 | 8 | 205 | 2 | IPR000547 | |
| Domain | Chond_GalNAc | 3.21e-03 | 8 | 205 | 2 | IPR008428 | |
| Domain | - | 3.21e-03 | 8 | 205 | 2 | 3.90.290.10 | |
| Domain | HEMATOPO_REC_S_F1 | 3.21e-03 | 8 | 205 | 2 | PS01355 | |
| Domain | P_TREFOIL_1 | 3.21e-03 | 8 | 205 | 2 | PS00025 | |
| Domain | CHGN | 3.21e-03 | 8 | 205 | 2 | PF05679 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 1.43e-05 | 14 | 159 | 4 | MM15047 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 5.29e-05 | 19 | 159 | 4 | M10959 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 7.56e-05 | 8 | 159 | 3 | MM14717 | |
| Pathway | REACTOME_DIGESTION | 8.03e-05 | 21 | 159 | 4 | MM15526 | |
| Pathway | REACTOME_DIGESTION | 1.17e-04 | 23 | 159 | 4 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 1.64e-04 | 25 | 159 | 4 | MM15557 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 2.17e-04 | 11 | 159 | 3 | M1091 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.23e-04 | 27 | 159 | 4 | M47755 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 2.58e-04 | 28 | 159 | 4 | M27837 | |
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 9647778 | ||
| Pubmed | 2.70e-08 | 15 | 219 | 5 | 2969332 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ACLY LAMA1 DNER ITGB4 MBOAT2 DMXL1 NRP2 CSDE1 IGSF10 FBN1 GLB1 P3H1 CHPF2 ECEL1 CHPF PLOD1 UBR2 ROR2 GPR107 TMEM106B FLCN PAM PCOLCE2 LTBP1 IL1RAP M6PR | 4.87e-08 | 1201 | 219 | 26 | 35696571 |
| Pubmed | DLGAP2 ARHGAP24 ABR HCN2 TENM2 KLHL7 SYNE2 NOS1 CNTN1 CACNA1E DNAJC13 ABI1 CAD DSCAM CAMK2B TRIOBP GRIA3 SPATA20 PPP2CB PPP6C MACF1 PRKD1 TP53BP1 | 5.36e-08 | 963 | 219 | 23 | 28671696 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | ACLY U2AF2 SYNE2 PLAT TDRD6 PLOD1 CLASRP PPP2CA PPP2CB MACF1 FBXO21 | 5.64e-08 | 197 | 219 | 11 | 20811636 |
| Pubmed | 2.28e-07 | 22 | 219 | 5 | 2527426 | ||
| Pubmed | PEG3 CSMD3 TENM2 PLEKHH1 CSDE1 SETDB1 PLCL2 CHPF2 PLXNB3 UBR2 MLXIP MACF1 SUZ12 SENP7 | 3.62e-07 | 407 | 219 | 14 | 12693553 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | CLTCL1 ACLY RRM2 PGAM1 ITGB4 SLC25A3 AARS2 FHL1 MOV10 CAD VTN PPP2CA PPP2CB DAZAP1 FBXO21 TP53BP1 XPOT | 8.77e-07 | 647 | 219 | 17 | 26618866 |
| Pubmed | 9.31e-07 | 52 | 219 | 6 | 26633812 | ||
| Pubmed | 9.70e-07 | 162 | 219 | 9 | 25826454 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 11175280 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 27169767 | ||
| Pubmed | 1.05e-06 | 13 | 219 | 4 | 10520995 | ||
| Pubmed | 1.83e-06 | 130 | 219 | 8 | 12421765 | ||
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 3.41e-06 | 17 | 219 | 4 | 17626059 | |
| Pubmed | A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity. | 4.37e-06 | 18 | 219 | 4 | 16085932 | |
| Pubmed | ZRSR2 PEG3 DNER NCAM2 PLEKHH1 CSDE1 SETDB1 FBN1 SACS KLHL7 FHL1 CHPF RECK PLXNB3 DSCAM TRIOBP DNAAF9 DAZAP1 SENP6 MACF1 HARS1 CADPS2 XPOT | 7.40e-06 | 1285 | 219 | 23 | 35914814 | |
| Pubmed | 8.46e-06 | 7 | 219 | 3 | 9237760 | ||
| Pubmed | 8.46e-06 | 7 | 219 | 3 | 17384681 | ||
| Pubmed | 8.46e-06 | 7 | 219 | 3 | 17145758 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ABR OBSCN BARD1 U2AF2 NCAM2 ACVR2B PLEKHH1 CSDE1 SCNN1A GNAS PLOD1 RECK UBR2 DNAJC13 CAMK2B ROR2 TRIOBP ARRB2 PPP4C DAZAP1 PLEKHG3 MACF1 PRKD1 FBXO21 RPAP2 | 8.72e-06 | 1489 | 219 | 25 | 28611215 |
| Pubmed | 1.35e-05 | 8 | 219 | 3 | 2938743 | ||
| Pubmed | 1.35e-05 | 8 | 219 | 3 | 35768646 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.80e-05 | 86 | 219 | 6 | 28327460 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | CLTCL1 ACLY PGAM1 SLC25A3 PTPN3 PIH1D1 CAD TRIOBP PPP2CA PPP2CB PPP4C PPP6C XPOT RPL18A | 1.86e-05 | 573 | 219 | 14 | 28330616 |
| Pubmed | Dynamic expression patterns of ECM molecules in the developing mouse olfactory pathway. | 2.01e-05 | 9 | 219 | 3 | 18570250 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | ABR BARD1 U2AF2 MOV10 CLASRP MRM3 PPP2CA PPP6C FLCN SUZ12 CDC27 HSPA14 TP53BP1 XPOT RPAP2 | 2.58e-05 | 670 | 219 | 15 | 22990118 |
| Pubmed | 2.78e-05 | 28 | 219 | 4 | 18617019 | ||
| Pubmed | A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype. | 3.91e-05 | 11 | 219 | 3 | 24623306 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 19062085 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 9840812 | ||
| Pubmed | Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. | 3.95e-05 | 2 | 219 | 2 | 9428515 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 33691379 | ||
| Pubmed | The N-Terminal Region of Fibrillin-1 Mediates a Bipartite Interaction with LTBP1. | 3.95e-05 | 2 | 219 | 2 | 28669633 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 11751260 | ||
| Pubmed | Convergence of inhibitory neural inputs regulate motor activity in the murine and monkey stomach. | 3.95e-05 | 2 | 219 | 2 | 27634009 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 35821240 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 22888001 | ||
| Pubmed | NOS1-dependent negative feedback regulation of the epithelial sodium channel in the collecting duct. | 3.95e-05 | 2 | 219 | 2 | 25391901 | |
| Pubmed | Inflammation-related gene variants as risk factors for pancreatic cancer. | 3.95e-05 | 2 | 219 | 2 | 21467233 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 38862034 | ||
| Pubmed | Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo. | 3.95e-05 | 2 | 219 | 2 | 21712364 | |
| Pubmed | CD226 and TIGIT Cooperate in the Differentiation and Maturation of Human Tfh Cells. | 3.95e-05 | 2 | 219 | 2 | 35273617 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 31135337 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 37596248 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 10543450 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 37175783 | ||
| Pubmed | The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function. | 3.95e-05 | 2 | 219 | 2 | 25465800 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 29515022 | ||
| Pubmed | β-Arrestin-2-Dependent Signaling Promotes CCR4-mediated Chemotaxis of Murine T-Helper Type 2 Cells. | 3.95e-05 | 2 | 219 | 2 | 29361236 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 27480812 | ||
| Pubmed | Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes. | 3.95e-05 | 2 | 219 | 2 | 1846293 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 35303175 | ||
| Pubmed | Structure and functional characterization of neuronal alpha 1E calcium channel subtypes. | 3.95e-05 | 2 | 219 | 2 | 8071363 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 20969868 | ||
| Pubmed | PP2A regulates kinetochore-microtubule attachment during meiosis I in oocyte. | 3.95e-05 | 2 | 219 | 2 | 27096707 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 22427644 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 24787007 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 32793241 | ||
| Pubmed | Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226. | 3.95e-05 | 2 | 219 | 2 | 25994968 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 20727575 | ||
| Pubmed | Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A. | 3.95e-05 | 2 | 219 | 2 | 2555176 | |
| Pubmed | Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN. | 3.95e-05 | 2 | 219 | 2 | 23150719 | |
| Pubmed | Epigenetic reactivation of PEG3 by EZH2 inhibitors suppresses renal clear cell carcinoma progress. | 3.95e-05 | 2 | 219 | 2 | 37001595 | |
| Pubmed | IL-7Rα Expression Regulates Murine Dendritic Cell Sensitivity to Thymic Stromal Lymphopoietin. | 3.95e-05 | 2 | 219 | 2 | 28404633 | |
| Pubmed | The semaphorin 7A receptor Plexin C1 is lost during melanoma metastasis. | 3.95e-05 | 2 | 219 | 2 | 19318806 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 32466852 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 32682212 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 26371162 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 38180241 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 29678764 | ||
| Pubmed | Characteristic of TIGIT and DNAM-1 Expression on Foxp3+ γδ T Cells in AML Patients. | 3.95e-05 | 2 | 219 | 2 | 32802845 | |
| Pubmed | FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. | 3.95e-05 | 2 | 219 | 2 | 22302939 | |
| Pubmed | DNAM-1 versus TIGIT: competitive roles in tumor immunity and inflammatory responses. | 3.95e-05 | 2 | 219 | 2 | 34694361 | |
| Pubmed | Expression of sucrase-isomaltase and dipeptidylpeptidase IV in human small intestine and colon. | 3.95e-05 | 2 | 219 | 2 | 1677636 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 24064353 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 11113010 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 36968271 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 32522890 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 31582819 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 24590984 | ||
| Pubmed | CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE. | 3.95e-05 | 2 | 219 | 2 | 31919790 | |
| Pubmed | Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities. | 3.95e-05 | 2 | 219 | 2 | 34902541 | |
| Pubmed | Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes. | 3.95e-05 | 2 | 219 | 2 | 2837763 | |
| Pubmed | Zrsr2 and functional U12-dependent spliceosome are necessary for follicular development. | 3.95e-05 | 2 | 219 | 2 | 35198906 | |
| Pubmed | The paired receptors TIGIT and DNAM-1 as targets for therapeutic antibodies. | 3.95e-05 | 2 | 219 | 2 | 28035916 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 20356844 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 37054890 | ||
| Pubmed | Absence of GNAS and EGFL6 mutations in common human cancers. | 3.95e-05 | 2 | 219 | 2 | 18038328 | |
| Pubmed | Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation. | 3.95e-05 | 2 | 219 | 2 | 24908670 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 24740233 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 25047840 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 18799455 | ||
| Pubmed | CLTCL1 TTC16 U2AF2 PGAM1 NRXN3 SACS SYNE2 DNAH6 CACNA1E PCDHGA9 PCDHGA4 CAMK2B GRK5 GRIA3 PPP2CA PPP2CB AVIL MACF1 ISG20L2 CADPS2 CDC27 MYBPC2 RPL18A | 4.50e-05 | 1442 | 219 | 23 | 35575683 | |
| Pubmed | Role for the MOV10 RNA helicase in polycomb-mediated repression of the INK4a tumor suppressor. | 5.20e-05 | 12 | 219 | 3 | 20543829 | |
| Pubmed | 5.20e-05 | 12 | 219 | 3 | 29287114 | ||
| Pubmed | 5.20e-05 | 12 | 219 | 3 | 28595999 | ||
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 5.20e-05 | 12 | 219 | 3 | 21270798 | |
| Pubmed | UBE2O and USP7 co-regulate RECQL4 ubiquitinylation and homologous recombination-mediated DNA repair. | 6.03e-05 | 155 | 219 | 7 | 34921745 | |
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 6.65e-05 | 67 | 219 | 5 | 16987237 | |
| Interaction | ST6GALNAC4 interactions | 4.44e-06 | 24 | 212 | 5 | int:ST6GALNAC4 | |
| Cytoband | 7p14 | 3.05e-07 | 30 | 219 | 5 | 7p14 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | PRTG IGFN1 PDGFRL OBSCN NCAM2 IGSF10 CD101 CNTN1 MXRA5 DSCAM NTRK3 ROR2 MYBPC2 | 1.41e-09 | 161 | 156 | 13 | 593 |
| GeneFamily | T cell receptor gamma locus at 7p14 | 1.05e-06 | 22 | 156 | 5 | 375 | |
| GeneFamily | Fibronectin type III domain containing | 1.29e-06 | 160 | 156 | 10 | 555 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 3.59e-06 | 13 | 156 | 4 | 693 | |
| GeneFamily | Dyneins, axonemal | 1.16e-05 | 17 | 156 | 4 | 536 | |
| GeneFamily | Immunoglobulin like domain containing | 4.62e-05 | 193 | 156 | 9 | 594 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.31e-04 | 57 | 156 | 5 | 1179 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | IL10RA ITGB4 CD101 CCR4 CCR8 DPP4 SEMA7A CR2 CD8A CD226 PLXNC1 IL7R | 1.63e-04 | 394 | 156 | 12 | 471 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.26e-04 | 206 | 156 | 8 | 682 | |
| GeneFamily | Ankyrin repeat domain containing|BRCA1 B complex | 4.39e-04 | 4 | 156 | 2 | 1335 | |
| GeneFamily | Classical arrestins | 4.39e-04 | 4 | 156 | 2 | 1312 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 5.39e-04 | 163 | 156 | 7 | 590 | |
| GeneFamily | Lysine methyltransferases|Myb/SANT domain containing|Polycomb repressive complex 2 | 1.08e-03 | 6 | 156 | 2 | 1347 | |
| GeneFamily | SUMO specific peptidases | 1.51e-03 | 7 | 156 | 2 | 984 | |
| GeneFamily | Plexins | 2.56e-03 | 9 | 156 | 2 | 683 | |
| GeneFamily | CD molecules|C-C motif chemokine receptors | 3.18e-03 | 10 | 156 | 2 | 1091 | |
| GeneFamily | Tudor domain containing | 3.95e-03 | 37 | 156 | 3 | 780 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 5.65e-03 | 42 | 156 | 3 | 602 | |
| GeneFamily | AT-rich interaction domain containing | 7.22e-03 | 15 | 156 | 2 | 418 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 7.22e-03 | 15 | 156 | 2 | 458 | |
| Coexpression | KRAS.PROSTATE_UP.V1_UP | 2.26e-07 | 137 | 217 | 10 | M2902 | |
| Coexpression | NABA_MATRISOME | LAMA1 HAPLN4 ZP2 F13B IGSF10 FBN1 OTOGL P3H1 ACAN FGF21 PLAT PLOD1 PLXNB3 VWC2 VTN SEMA7A KCP EGFL6 SERPINA11 ADAMTS6 PLXNC1 PCOLCE2 LTBP1 SEMA3E | 3.67e-06 | 1008 | 217 | 24 | MM17056 |
| Coexpression | NABA_MATRISOME | LAMA1 HAPLN4 ZP2 F13B IGSF10 FBN1 P3H1 ACAN FGF21 PLAT PLOD1 PLXNB3 VWC2 MXRA5 VTN SEMA7A KCP EGFL6 SERPINA11 ADAMTS6 PLXNC1 PCOLCE2 LTBP1 SEMA3E | 4.95e-06 | 1026 | 217 | 24 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | LAMA1 HAPLN4 ZP2 IGSF10 FBN1 OTOGL ACAN VTN KCP PCOLCE2 LTBP1 | 1.70e-05 | 270 | 217 | 11 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | LAMA1 HAPLN4 ZP2 IGSF10 FBN1 ACAN MXRA5 VTN KCP PCOLCE2 LTBP1 | 2.01e-05 | 275 | 217 | 11 | M5884 |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_UP | 3.07e-05 | 146 | 217 | 8 | MM964 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.25e-05 | 191 | 217 | 9 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.97e-05 | 196 | 217 | 9 | M3008 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP | 4.30e-05 | 198 | 217 | 9 | M5152 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_UP | 4.47e-05 | 199 | 217 | 9 | M3915 | |
| Coexpression | GSE6259_DEC205_POS_DC_VS_CD8_TCELL_DN | 4.50e-05 | 154 | 217 | 8 | M6776 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP | 4.65e-05 | 200 | 217 | 9 | M7295 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | ARHGAP24 U2AF2 DMXL1 SACS SYNE2 PLCL2 GNAL FHL1 UBR2 DNAJC13 TOPBP1 GPR107 PPP2CB ZNF713 PPP6C CNOT9 PLXNC1 SENP6 MACF1 CTBS SUZ12 HARS1 M6PR CAPN15 | 7.57e-05 | 1215 | 217 | 24 | M41122 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | NCAM2 NRP2 FHL1 CNTN1 CACNA1D NTRK3 HIF3A EGFL6 MACF1 CADPS2 SEMA3E | 3.57e-09 | 194 | 219 | 11 | 71d3c7448b1734de54187f902f65649f9283bd4c |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 LAMA1 OBSCN NCAM2 CSMD3 PPARGC1A OTOGL DNAH9 CNTN1 MGAM | 2.78e-08 | 184 | 219 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 LAMA1 OBSCN NCAM2 CSMD3 PPARGC1A OTOGL DNAH9 CNTN1 MGAM | 2.78e-08 | 184 | 219 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 LAMA1 OBSCN NCAM2 CSMD3 PPARGC1A OTOGL DNAH9 CNTN1 MGAM | 2.78e-08 | 184 | 219 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.77e-08 | 190 | 219 | 10 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | PEG3 NRP2 IGSF10 FBN1 FHL1 CACNA1D PCDHGA9 GRIA3 MACF1 PCOLCE2 | 4.16e-08 | 192 | 219 | 10 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | PEG3 NRP2 IGSF10 FBN1 FHL1 CACNA1D PCDHGA9 GRIA3 MACF1 PCOLCE2 | 4.16e-08 | 192 | 219 | 10 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | NCAM2 NRP2 FHL1 CNTN1 CACNA1D HIF3A EGFL6 MACF1 CADPS2 SEMA3E | 4.37e-08 | 193 | 219 | 10 | 9f69edc97b868d23998abc98928a2e89a885ef8a |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.37e-08 | 193 | 219 | 10 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.37e-08 | 193 | 219 | 10 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | PEG3 NRP2 IGSF10 FBN1 FHL1 CACNA1D PCDHGA9 GRIA3 MACF1 PCOLCE2 | 4.81e-08 | 195 | 219 | 10 | 3a0cad69cfc150a27a0666f612f5294c817197d7 |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | PEG3 NRP2 IGSF10 FBN1 FHL1 CACNA1D PCDHGA9 GRIA3 MACF1 PCOLCE2 | 4.81e-08 | 195 | 219 | 10 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.05e-08 | 196 | 219 | 10 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.05e-08 | 196 | 219 | 10 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_CTL|World / disease group, cell group and cell class (v2) | 5.55e-08 | 198 | 219 | 10 | 03c01fc384d46eec55ff730edbab8a3fde618ed8 | |
| ToppCell | COVID-19_Moderate-CD4+_CTL|COVID-19_Moderate / disease group, cell group and cell class | 6.10e-08 | 200 | 219 | 10 | a9c73559e2c9fda1b065bfb5ce84978995505924 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-07 | 160 | 219 | 9 | 8a7a73b0ee1877fe02d47f745d36ae2858b529e1 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-07 | 167 | 219 | 9 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.02e-07 | 173 | 219 | 9 | 36a471576a9d2325066bb14c2f2cd89c67b92915 | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-07 | 177 | 219 | 9 | 7853430fb0d1a18d835e8956777e0616c5d7d412 | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-07 | 177 | 219 | 9 | 9a5bf67a801826d094f679dd2189b62296c9694f | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-07 | 177 | 219 | 9 | 395f005f019aabb18738d3a10a04c37f216deda3 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.71e-07 | 130 | 219 | 8 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-07 | 182 | 219 | 9 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-07 | 182 | 219 | 9 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.26e-07 | 189 | 219 | 9 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP24 LAMA1 DNER PPARGC1A SCNN1A NOS1 CACNA1D USP24 PRKD1 | 4.26e-07 | 189 | 219 | 9 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-07 | 190 | 219 | 9 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-07 | 191 | 219 | 9 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | (12)_SLC16A7+|World / shred by cell type by condition | 4.66e-07 | 191 | 219 | 9 | e427eeddd2e87c14376a37db0b43f120c90436bc | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.87e-07 | 192 | 219 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Th17|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.08e-07 | 193 | 219 | 9 | 4112eed9327e1d5a7e829fce6b2437287e14464e | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Trm_gut_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.31e-07 | 194 | 219 | 9 | e9db509ff75f8605365841276fac6cec66ae27c7 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-07 | 195 | 219 | 9 | b616ee6f1d878935d293c8e0a8bbc5b4385301f0 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-07 | 195 | 219 | 9 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-07 | 195 | 219 | 9 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-07 | 195 | 219 | 9 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-07 | 195 | 219 | 9 | 2f9a274b26fc528a85f50933ec2f4db1dc9da0ca | |
| ToppCell | COVID-19-Lymphoid-CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 5.54e-07 | 195 | 219 | 9 | d4c70a462b98963e78f4e2659574bc350f8ffe1a | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-07 | 195 | 219 | 9 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.78e-07 | 196 | 219 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.30e-07 | 198 | 219 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.30e-07 | 198 | 219 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.30e-07 | 198 | 219 | 9 | 02d0d8a212e09c0962ab1dae6a885d26d357f66a | |
| ToppCell | (0)_NK_cells-(0)_NK_FCGR3Apos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.30e-07 | 198 | 219 | 9 | eba39656c6f699ab297b652ded8cb9727b49593c | |
| ToppCell | VE-CD8|VE / Condition, Cell_class and T cell subcluster | 6.57e-07 | 199 | 219 | 9 | 9ae4d3e93b6e0861258e567c901ec34f04ded547 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-T|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.57e-07 | 199 | 219 | 9 | f53190b7e236b46a7ffca52977b9ad39831f66f4 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.57e-07 | 199 | 219 | 9 | 8c4ebdedfb808cf2fc6629295b4d3fab8e562053 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.57e-07 | 199 | 219 | 9 | 28b12df9b899784bf405c5d52a0d43fd1a6c6b62 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 6.57e-07 | 199 | 219 | 9 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.57e-07 | 199 | 219 | 9 | 7345b424b27951cd55f7f06f9503a7d44a881cd1 | |
| ToppCell | COVID-19_Moderate-CD4+_CTL|World / disease group, cell group and cell class | 6.57e-07 | 199 | 219 | 9 | 12ea0346b4da3e8e2b3b2b3b3e9d4f4f104345a6 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.57e-07 | 199 | 219 | 9 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.85e-07 | 200 | 219 | 9 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD8|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.85e-07 | 200 | 219 | 9 | 8b8c07a16c91bd6e0d276fba1472d0d314e03416 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.25e-06 | 159 | 219 | 8 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B2|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-06 | 162 | 219 | 8 | 59c0dcb5b51c1803660aeec51b60deceeeaeea66 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 116 | 219 | 7 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-06 | 167 | 219 | 8 | 859dfe0764cb69de27e79e1c1aa65f9d538f79ea | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.35e-06 | 173 | 219 | 8 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 2.35e-06 | 173 | 219 | 8 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.46e-06 | 174 | 219 | 8 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.67e-06 | 176 | 219 | 8 | 6b06da40eb97ea2db09f3a769494738b3e5fe3fa | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-06 | 176 | 219 | 8 | 581045e61cdcdfa85701343d1a7c0a72a36606a7 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 182 | 219 | 8 | eb4be1c02b8b033d025e57b8b4cdbfaec4698054 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.43e-06 | 182 | 219 | 8 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.72e-06 | 184 | 219 | 8 | bc394eaa441fcaffcc4ace062741bca1da229324 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.72e-06 | 184 | 219 | 8 | 54e5b63f55b8d6eccad53d389ea9c78f991e1414 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.72e-06 | 184 | 219 | 8 | 7b5678718719020b52e7c2a7bd9797987defd7ff | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-06 | 185 | 219 | 8 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.87e-06 | 185 | 219 | 8 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.87e-06 | 185 | 219 | 8 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-06 | 186 | 219 | 8 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | Healthy-MAIT|Healthy / disease group, cell group and cell class | 4.03e-06 | 186 | 219 | 8 | 028061f06d86e75cb06db56b199594b80f23fa58 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.03e-06 | 186 | 219 | 8 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.03e-06 | 186 | 219 | 8 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-06 | 187 | 219 | 8 | a0bd2b0ec9e73521c245037b1dd51ff8cf24cbf5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.19e-06 | 187 | 219 | 8 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-06 | 187 | 219 | 8 | f2af79a20438108c814a73f9e24cd986d537237f | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 4.36e-06 | 188 | 219 | 8 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.36e-06 | 188 | 219 | 8 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-06 | 188 | 219 | 8 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.71e-06 | 190 | 219 | 8 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.71e-06 | 190 | 219 | 8 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.71e-06 | 190 | 219 | 8 | 66d29f53f129fc18771f6214316a913eeaccd55e | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 4.71e-06 | 190 | 219 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.90e-06 | 191 | 219 | 8 | 053b3664f509baa107feaf90730f80ebf9ac8f14 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.90e-06 | 191 | 219 | 8 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.90e-06 | 191 | 219 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.90e-06 | 191 | 219 | 8 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.90e-06 | 191 | 219 | 8 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.09e-06 | 192 | 219 | 8 | ab88ea7723f0fa3b39611981c043445f27425404 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-06 | 193 | 219 | 8 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-NKT1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.29e-06 | 193 | 219 | 8 | 52f42ec293a5077a44de5c27e89b57c23944e560 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-NKT2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.29e-06 | 193 | 219 | 8 | bae37ec161fad7c91edc674a2c7808b51c9a8135 | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-06 | 194 | 219 | 8 | da45811ba07d746e7cba7ed78882b5d98ac7397d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.49e-06 | 194 | 219 | 8 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.49e-06 | 194 | 219 | 8 | ecdfc27d06e363fb23f0309f26ef6404a89f14ec | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.49e-06 | 194 | 219 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-06 | 194 | 219 | 8 | 76b8512fd92014b3ecc42b0a20d6d1df074cba2c | |
| Drug | valienamine | 2.67e-06 | 125 | 212 | 9 | CID000193758 | |
| Drug | nimbidiol | 3.16e-06 | 4 | 212 | 3 | ctd:C496111 | |
| Drug | Bluo-gal | 3.41e-06 | 12 | 212 | 4 | CID000126898 | |
| Drug | maltulose | 3.65e-06 | 45 | 212 | 6 | CID000087177 | |
| Drug | valiolamine | 4.89e-06 | 13 | 212 | 4 | CID000174312 | |
| Drug | MDL 25,637 | 4.89e-06 | 13 | 212 | 4 | CID000128548 | |
| Drug | AC1OAGYH | 9.20e-06 | 15 | 212 | 4 | CID006857622 | |
| Drug | Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; HL60; HT_HG-U133A | 1.54e-05 | 195 | 212 | 10 | 2736_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 1.54e-05 | 195 | 212 | 10 | 5582_UP | |
| Drug | AC1NSEO1 | 1.56e-05 | 6 | 212 | 3 | CID005360200 | |
| Drug | fagomine | 1.58e-05 | 17 | 212 | 4 | CID000072259 | |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | IL10RA NRXN3 ACAN PLCL2 CNTN1 NTRK3 CRYGB ARNT PLXNC1 FBXO21 | 1.68e-05 | 197 | 212 | 10 | 5741_UP |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Down 200; 8.6uM; PC3; HT_HG-U133A | CLTCL1 U2AF2 ITGB4 LIN7B GPR107 ARRB2 PLXNC1 PLEKHG3 SENP7 CAPN15 | 1.76e-05 | 198 | 212 | 10 | 4193_DN |
| Drug | Graveoline [485-61-0]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.83e-05 | 199 | 212 | 10 | 3614_UP | |
| Drug | urea-formaldehyde | 2.71e-05 | 7 | 212 | 3 | CID000062705 | |
| Drug | N-acetylhexosamine | IL10RA NCAM2 ITGB4 NRP2 GLB1 ACAN GNAS CHPF DPP4 MGAM VTN CD8A CTBS M6PR IL7R | 3.92e-05 | 472 | 212 | 15 | CID000000899 |
| Drug | zirconium phosphate | 4.31e-05 | 8 | 212 | 3 | CID000160986 | |
| Drug | NSC226080 | CLTCL1 ARID4B DNER ACVR2B PPARGC1A FBN1 ACAN NTRK3 ROR2 EIF5A2 PPP2CA PPP2CB ARNT PPP4C PPP6C FLCN PRKD1 HARS1 M6PR XPOT | 4.61e-05 | 782 | 212 | 20 | CID000005040 |
| Drug | NSC624987 | 4.69e-05 | 22 | 212 | 4 | CID000001472 | |
| Drug | emiglitate | 4.69e-05 | 22 | 212 | 4 | CID000072004 | |
| Disease | Colorectal Carcinoma | ABCA3 PDGFRL PEG3 LAMA1 OBSCN RRM2 CSMD3 SACS GNAS CNTN1 DNAH3 VPS18 CAD ARNT ARAP3 CD226 FLCN PRKD1 | 2.27e-06 | 702 | 205 | 18 | C0009402 |
| Disease | osteoarthritis | 1.72e-04 | 222 | 205 | 8 | MONDO_0005178 | |
| Disease | depressive symptom measurement | DLGAP2 TENM2 PPARGC1A SYNE2 BTN1A1 PLCL2 NOS1 CACNA1E TMEM106B PRKD1 SEMA3E | 2.10e-04 | 426 | 205 | 11 | EFO_0007006 |
| Disease | glomerulonephritis (biomarker_via_orthology) | 3.45e-04 | 20 | 205 | 3 | DOID:2921 (biomarker_via_orthology) | |
| Disease | Weaver syndrome | 4.74e-04 | 5 | 205 | 2 | C0265210 | |
| Disease | Schizophrenia | IL10RA DLGAP2 LAMA1 PPARGC1A SETDB1 NRXN3 PLCL2 PLAT GNAL GNAS NOS1 CAMK2B NTRK3 GRIA3 DAZAP1 CADPS2 | 4.81e-04 | 883 | 205 | 16 | C0036341 |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 5.86e-04 | 147 | 205 | 6 | DOID:9352 (biomarker_via_orthology) | |
| Disease | beta-aminoisobutyric acid measurement | 6.01e-04 | 24 | 205 | 3 | EFO_0010464 | |
| Disease | complement factor H-related protein 1 measurement | 6.26e-04 | 56 | 205 | 4 | EFO_0600054 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.99e-04 | 152 | 205 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Emery-Dreifuss muscular dystrophy | 7.07e-04 | 6 | 205 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 7.07e-04 | 6 | 205 | 2 | C0410189 | |
| Disease | oligoasthenoteratozoospermia (implicated_via_orthology) | 7.07e-04 | 6 | 205 | 2 | DOID:0070311 (implicated_via_orthology) | |
| Disease | interleukin 17 receptor B measurement | 7.07e-04 | 6 | 205 | 2 | EFO_0008176 | |
| Disease | neurotic disorder | 7.11e-04 | 101 | 205 | 5 | EFO_0004257 | |
| Disease | Cholangiocarcinoma | 7.64e-04 | 26 | 205 | 3 | C0206698 | |
| Disease | Seizures | 8.65e-04 | 218 | 205 | 7 | C0036572 | |
| Disease | Endometrioma | 9.43e-04 | 161 | 205 | 6 | C0269102 | |
| Disease | Endometriosis | 9.43e-04 | 161 | 205 | 6 | C0014175 | |
| Disease | interleukin 5 measurement | 9.52e-04 | 28 | 205 | 3 | EFO_0008185 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 9.86e-04 | 7 | 205 | 2 | C0751337 | |
| Disease | 1,5 anhydroglucitol measurement | 1.06e-03 | 29 | 205 | 3 | EFO_0008009 | |
| Disease | serum IgG glycosylation measurement | ARHGAP24 GPR85 DNER CHPF2 RECK CNTN1 CACNA1E DSCAM TMEM106B FLCN PRKD1 | 1.15e-03 | 523 | 205 | 11 | EFO_0005193 |
| Disease | Parkinson's disease (is_marker_for) | 1.23e-03 | 67 | 205 | 4 | DOID:14330 (is_marker_for) | |
| Disease | Prescription Drug Abuse | 1.27e-03 | 115 | 205 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 1.27e-03 | 115 | 205 | 5 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.27e-03 | 115 | 205 | 5 | C0029231 | |
| Disease | Drug habituation | 1.27e-03 | 115 | 205 | 5 | C0013170 | |
| Disease | Drug abuse | 1.27e-03 | 115 | 205 | 5 | C0013146 | |
| Disease | Drug Use Disorders | 1.27e-03 | 115 | 205 | 5 | C0013222 | |
| Disease | Drug Dependence | 1.27e-03 | 115 | 205 | 5 | C1510472 | |
| Disease | Substance Dependence | 1.27e-03 | 115 | 205 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 1.27e-03 | 115 | 205 | 5 | C0038586 | |
| Disease | cathepsin S measurement | 1.31e-03 | 8 | 205 | 2 | EFO_0008073 | |
| Disease | pantothenate measurement | 1.31e-03 | 8 | 205 | 2 | EFO_0021034 | |
| Disease | Substance abuse problem | 1.32e-03 | 116 | 205 | 5 | C0740858 | |
| Disease | urate measurement, bone density | DLGAP2 ARHGAP24 DNER HCN2 TENM2 PPARGC1A DNAH9 DSCAM THAP9 GPR107 PLXNC1 CADPS2 | 1.39e-03 | 619 | 205 | 12 | EFO_0003923, EFO_0004531 |
| Disease | Malignant neoplasm of breast | ABCA3 OBSCN HAPLN4 BARD1 EZH2 APOBEC3A OTOGL SYNE2 PLOD1 DNAH9 CLASRP ARAP3 DAZAP1 MACF1 CDC27 HSPA14 TP53BP1 | 1.43e-03 | 1074 | 205 | 17 | C0006142 |
| Disease | Malignant Glioma | 1.45e-03 | 70 | 205 | 4 | C0555198 | |
| Disease | mixed gliomas | 1.45e-03 | 70 | 205 | 4 | C0259783 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.53e-03 | 71 | 205 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | Hypoxemia | 1.55e-03 | 33 | 205 | 3 | C0700292 | |
| Disease | Hypoxia | 1.55e-03 | 33 | 205 | 3 | C0242184 | |
| Disease | Anoxemia | 1.55e-03 | 33 | 205 | 3 | C0003129 | |
| Disease | Anoxia | 1.55e-03 | 33 | 205 | 3 | C0003130 | |
| Disease | colorectal cancer (is_implicated_in) | 1.60e-03 | 121 | 205 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | Liver Diseases, Parasitic | 1.67e-03 | 9 | 205 | 2 | C0023897 | |
| Disease | Situs ambiguous | 1.67e-03 | 9 | 205 | 2 | C1167664 | |
| Disease | CCL17 measurement | 1.67e-03 | 9 | 205 | 2 | EFO_0009414 | |
| Disease | endothelin-converting enzyme 1 measurement | 1.67e-03 | 9 | 205 | 2 | EFO_0008121 | |
| Disease | refractive error, self reported educational attainment | 1.69e-03 | 34 | 205 | 3 | EFO_0004784, MONDO_0004892 | |
| Disease | Amphetamine-Related Disorders | 1.87e-03 | 75 | 205 | 4 | C0236733 | |
| Disease | Amphetamine Abuse | 1.87e-03 | 75 | 205 | 4 | C0236807 | |
| Disease | Amphetamine Addiction | 1.87e-03 | 75 | 205 | 4 | C0236804 | |
| Disease | Renal Cell Carcinoma | 2.04e-03 | 128 | 205 | 5 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.04e-03 | 128 | 205 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.04e-03 | 128 | 205 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.04e-03 | 128 | 205 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.04e-03 | 128 | 205 | 5 | C1306837 | |
| Disease | Hyperpotassemia and Hypertension, Familial | 2.08e-03 | 10 | 205 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 2.08e-03 | 10 | 205 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 2.08e-03 | 10 | 205 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 2.08e-03 | 10 | 205 | 2 | C1449842 | |
| Disease | Marfan syndrome (implicated_via_orthology) | 2.08e-03 | 10 | 205 | 2 | DOID:14323 (implicated_via_orthology) | |
| Disease | Pseudohypoaldosteronism, Type I | 2.08e-03 | 10 | 205 | 2 | C0268436 | |
| Disease | renal Wilms' tumor (is_implicated_in) | 2.08e-03 | 10 | 205 | 2 | DOID:5176 (is_implicated_in) | |
| Disease | PR segment | 2.08e-03 | 10 | 205 | 2 | EFO_0005095 | |
| Disease | Pseudohypoaldosteronism | 2.08e-03 | 10 | 205 | 2 | C0033805 | |
| Disease | Autistic Disorder | 2.42e-03 | 261 | 205 | 7 | C0004352 | |
| Disease | Situs Inversus | 2.54e-03 | 11 | 205 | 2 | C0037221 | |
| Disease | hepatocellular carcinoma | 2.90e-03 | 41 | 205 | 3 | EFO_0000182 | |
| Disease | triacylglycerol 58:12 measurement | 3.03e-03 | 12 | 205 | 2 | EFO_0010439 | |
| Disease | C-C motif chemokine 17 measurement | 3.03e-03 | 12 | 205 | 2 | EFO_0008045 | |
| Disease | Abruptio Placentae | 3.03e-03 | 12 | 205 | 2 | EFO_1001754 | |
| Disease | Glioma | 3.21e-03 | 87 | 205 | 4 | C0017638 | |
| Disease | Colorectal Neoplasms | 3.36e-03 | 277 | 205 | 7 | C0009404 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 3.78e-03 | 45 | 205 | 3 | DOID:8947 (biomarker_via_orthology) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.82e-03 | 148 | 205 | 5 | C0279702 | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 4.12e-03 | 216 | 205 | 6 | EFO_0007925, EFO_0007927 | |
| Disease | malignant pleural mesothelioma (is_marker_for) | 4.14e-03 | 14 | 205 | 2 | DOID:7474 (is_marker_for) | |
| Disease | sulfate measurement | 4.14e-03 | 14 | 205 | 2 | EFO_0007864 | |
| Disease | pulse pressure measurement, social deprivation | 4.14e-03 | 14 | 205 | 2 | EFO_0005763, EFO_0009696 | |
| Disease | Intellectual Disability | 4.23e-03 | 447 | 205 | 9 | C3714756 | |
| Disease | cerebral amyloid deposition measurement | 4.40e-03 | 95 | 205 | 4 | EFO_0007707 | |
| Disease | Adenocarcinoma of large intestine | 4.57e-03 | 96 | 205 | 4 | C1319315 | |
| Disease | impotence (implicated_via_orthology) | 4.75e-03 | 15 | 205 | 2 | DOID:1875 (implicated_via_orthology) | |
| Disease | mannan-binding lectin serine protease 1 measurement | 4.75e-03 | 15 | 205 | 2 | EFO_0008223 | |
| Disease | Situs ambiguus | 4.75e-03 | 15 | 205 | 2 | C0266642 | |
| Disease | obsolete aging, cognition | 4.75e-03 | 15 | 205 | 2 | EFO_0003925, GO_0007568 | |
| Disease | Non-Small Cell Lung Carcinoma | 4.77e-03 | 156 | 205 | 5 | C0007131 | |
| Disease | glycerophospholipid measurement | 4.81e-03 | 49 | 205 | 3 | EFO_0007630 | |
| Disease | Tourette syndrome | 5.09e-03 | 50 | 205 | 3 | EFO_0004895 | |
| Disease | alcohol consumption measurement | DLGAP2 ACVR2B CSMD3 TENM2 MBOAT2 NRXN3 FGF21 CACNA1D CACNA1E DPP4 MGAM MMS22L CAD PPP4C ARID2 SENP6 SENP7 | 6.20e-03 | 1242 | 205 | 17 | EFO_0007878 |
| Disease | body mass index, osteoarthritis | 6.32e-03 | 54 | 205 | 3 | EFO_0004340, MONDO_0005178 | |
| Disease | neuroticism measurement, cognitive function measurement | PLCL2 NOS1 CACNA1E DPP4 MMS22L DSCAM TMEM106B PPP6C SEMA3E MYBPC2 | 6.49e-03 | 566 | 205 | 10 | EFO_0007660, EFO_0008354 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NLYCTLEVDSFGYFV | 521 | Q12979 | |
| EDNGIYQCYFQEGRS | 116 | Q96KV6 | |
| YGFEEYCRSANIEFQ | 391 | Q4LE39 | |
| FQNPYSDEIEYIICT | 446 | P27540 | |
| YQYFVSGICQDITRN | 2096 | Q96N23 | |
| NFYEGDCYVILSTRR | 36 | O75366 | |
| FELQYISGRYDCIDI | 206 | Q8IUX8 | |
| SCQVFLYQRSGEESY | 151 | Q96HD9 | |
| NEVVVRATYSGFLYC | 671 | Q8WWN8 | |
| PDSDQRFCTQYIIYE | 726 | Q99728 | |
| TDYLVGTRVTYFCND | 2646 | Q7Z407 | |
| NERCGTDLAYVYFVS | 1691 | Q15878 | |
| EYTCFFREDGSYEEA | 121 | Q13410 | |
| TYLCYEVERLDNGTS | 31 | P31941 | |
| DNGVLICEYVDQDSY | 386 | Q68CP9 | |
| LDDTGLAYICQTYER | 191 | Q92600 | |
| FEDYIRYDNCSSSVL | 116 | Q99758 | |
| LTRVADYCENNYIQA | 26 | Q8IZP0 | |
| YVSDGYCNSRIVQFS | 646 | P19021 | |
| GSVCYERNGEVFYLT | 126 | O75534 | |
| YLRAIQAGYSQDDEC | 571 | Q9P1A6 | |
| EVLQDCTFERYLDYA | 271 | P51679 | |
| CTFERYLDYAIQATE | 276 | P51679 | |
| VYVTLTCAFRYGQED | 61 | P10523 | |
| TLSDFRRENEGYYFC | 101 | P01732 | |
| RRENEGYYFCSALSN | 106 | P01732 | |
| NIDRRCYNYTGIADA | 186 | Q01459 | |
| SLEIYEYQGCQAAED | 81 | Q7L5Y6 | |
| QDSTYGDEDCLYLNI | 91 | P19835 | |
| LRSYFSQYGEVVDCV | 26 | Q96EP5 | |
| CFVASDGQYLRLYEA | 761 | Q9Y485 | |
| VRQYADICLFSTAQY | 236 | P32121 | |
| GQVYDADEQCRFQYG | 481 | Q9UKP5 | |
| ALNCLAEGYNFYTER | 651 | Q9UKP5 | |
| LFGQTAEDYAVCYNF | 231 | Q9H560 | |
| AEDYAVCYNFRSIQQ | 236 | Q9H560 | |
| CRENYGLEFQVIDLY | 71 | Q9ULI1 | |
| SDRVAVDYYGDCQAV | 776 | O95980 | |
| DGFSSYLDEDVNYCI | 96 | Q5VW38 | |
| ALQEYFVAYEECRAL | 231 | Q32P28 | |
| CYINIARTLDFYGVE | 206 | P26045 | |
| EYGDFVRYFDSVDIC | 776 | O75808 | |
| NTGILYALCSFDYEQ | 541 | Q9Y5G9 | |
| YALCSFDYEQFRDLQ | 546 | Q9Y5G9 | |
| YNVLVEDGSCRYAAQ | 551 | O94952 | |
| EDGSCRYAAQENLEY | 556 | O94952 | |
| CAFNDRVYATYQVTR | 296 | P47900 | |
| LAAAAVEEQYSCDYG | 46 | Q00325 | |
| CFEITTANVVYYVGE | 491 | Q15139 | |
| FCSAIREVYEQLYDT | 46 | Q9HAP6 | |
| TVCQVTRVYIFDYGQ | 111 | Q6ZWT7 | |
| SSQYEEAYRCNFLGL | 406 | Q8NFG4 | |
| EYYQEGEISEGCLLF | 351 | Q16288 | |
| IFYQSYEELGRLEAC | 1996 | Q38SD2 | |
| YFYGILQSDASERCD | 11 | Q9NPH3 | |
| IYIDGVQEVFETSYC | 626 | Q6ZRQ5 | |
| RNDYQLICIQDGYLS | 86 | Q9GZV4 | |
| FQLCRYGYQNDSEIA | 1246 | O43451 | |
| FCYFVNDLYSVSDVQ | 1891 | O43451 | |
| ITVQVENEYGSYFAC | 181 | P16278 | |
| DTYENGSSVEYRCFD | 541 | P05160 | |
| EGNERYEGYCVDLAY | 446 | P42263 | |
| IQTGEELFFDYRYSQ | 716 | Q15910 | |
| QAEYRSYVARVCLGD | 256 | Q9ULL4 | |
| LRVQDTYLDCGTLQY | 826 | O60486 | |
| SRVEAEDVGVYYCTQ | 101 | A0A075B6R9 | |
| YEGYRFSEQQRKCVD | 901 | Q14766 | |
| FERVYRAQVNCSEYF | 46 | Q16873 | |
| TGVLYALCSFDYEQF | 511 | Q9Y5G4 | |
| CSFRELLLEDGYNVY | 121 | Q9NSA1 | |
| SCTTLENYNFELYDG | 901 | O60462 | |
| ENVATFRGSEYLCYD | 256 | Q9Y4C0 | |
| LANEFRCYVNYDSGL | 196 | Q8WVE0 | |
| CSIVNYNGDVLYDEY | 201 | Q9H9L3 | |
| YDTRLDCGYFNTLDS | 531 | O94854 | |
| ADVFCLNTYYSRIVQ | 1201 | P09848 | |
| SNEEGYRHICYFQID | 376 | P27487 | |
| DDYSFSCYSQLEVNG | 36 | P16871 | |
| QSESTCYEVALLRYG | 51 | Q13651 | |
| EVGNSALYLFECYDT | 391 | Q8IXQ5 | |
| ESDNLCRYDFVDVYN | 81 | Q9UKZ9 | |
| RQITQVYGFYDECLR | 121 | P62714 | |
| RQITQVYGFYDECLR | 121 | P67775 | |
| RFNGDEAYDQCTNYL | 61 | Q9HC73 | |
| TAYEVCYGLVNDDNR | 1251 | P16144 | |
| SYNYGSEDQAEFLCV | 176 | Q8N5Z5 | |
| YDEFQEVKYVSRCGA | 11 | O95672 | |
| SEYQRDYTGEQLYEC | 1151 | Q9GZU2 | |
| SSRYDAICYTGEDFV | 341 | P16112 | |
| TYDVYCFVDRLEGEV | 566 | P16112 | |
| YEINSLVRYQCTEGF | 2466 | P16112 | |
| QDRSCTYYFSVDADV | 371 | Q02809 | |
| TEIGVRDYCDNSRYN | 596 | P29475 | |
| QIYDVSQRDSGNYRC | 191 | Q2VWP7 | |
| ERSNEYQLIDCAQYF | 151 | P38405 | |
| SLTIYRCEFADQGVY | 2221 | Q5VST9 | |
| TYRYTCDAFAALENG | 721 | Q9UBK2 | |
| GYDFDTVNKQTCQTY | 96 | Q9HAP2 | |
| YICRFLDEVQSYSGV | 266 | Q8N264 | |
| GNVEECYRYFTSVLF | 161 | A1A4V9 | |
| AGQRFTAVEDQYYCV | 196 | Q13642 | |
| GLYDCQTRQNELLYT | 71 | A4D1B5 | |
| YGAFTAQYRQSLIEC | 3006 | Q9C0G6 | |
| EILRVTLYCSFDNYE | 136 | Q9H5Z6 | |
| VAEEGDYTCYAQNTL | 2111 | Q6WRI0 | |
| GVYQCEVEVYDRNSL | 636 | Q93033 | |
| ENFLYGNEVSYECDQ | 736 | P20023 | |
| NICDAQIQYSYEYLG | 1801 | Q9UFH2 | |
| VAYLGAFTVDYRVQC | 3006 | Q8TD57 | |
| EVRYEVNCSGIYEQE | 66 | Q9P109 | |
| DNIYISTYFCQIDDR | 406 | Q5T197 | |
| GYYLNEDTRVCDDVN | 1636 | P35555 | |
| FYQVASEDGVLQCYS | 171 | P51685 | |
| CIAENTYGAIYANAE | 391 | Q12860 | |
| IQVENEYGSYRACDF | 181 | Q6UWU2 | |
| IDSRYNEGCRELANY | 56 | Q5TEA3 | |
| DEGVRACYERSNEYQ | 156 | P63092 | |
| IVADEAFCNAVRSYY | 136 | Q86UW7 | |
| FYEDRAFQGRSYECT | 6 | P07316 | |
| SRVEYQCQSYYELQG | 481 | Q92496 | |
| RVLCSYDYRNIEGFV | 146 | O75165 | |
| GTYSFIREEDQCTFQ | 161 | P60893 | |
| RNVTLQDYGRYECEV | 131 | Q86UW8 | |
| QDYGRYECEVTNELE | 136 | Q86UW8 | |
| EDTDLYRCTAVNAYG | 96 | Q86VF2 | |
| FSVYQYTIRGLFECD | 3736 | Q9NYC9 | |
| RVYDYESERLDCFQS | 6976 | Q8NDH2 | |
| DVTVSDSGLYRCYLQ | 211 | Q15762 | |
| GLECYIQFLDSVAEY | 76 | P34947 | |
| DLVFEEACGYYQRRS | 401 | Q86YV9 | |
| QYVGTFCEEYDACQR | 341 | Q8NFT8 | |
| AYEEFYNCRSIDSEF | 676 | Q8NFT8 | |
| CFYQTYSSGVDAVRE | 236 | P37088 | |
| DGITLYQENITNACY | 2306 | Q9NZJ4 | |
| FENYCRNDDLVTFGR | 231 | Q08AI6 | |
| VLCQIGRAYFELSEY | 501 | P30260 | |
| GRYREFYQCDFDIAG | 166 | P12081 | |
| TYCRLYSLSVDNFNE | 626 | Q9UL51 | |
| DCGNRSFYDLEADQY | 366 | H0Y7S4 | |
| EEYTCGSNFAIVYFI | 1431 | Q01668 | |
| RDAGYEFDICFTSVQ | 46 | P18669 | |
| GLEYDYISDCQVFLI | 961 | Q3ZCN5 | |
| YEGQDFDCNVSRARF | 286 | Q0VDF9 | |
| DQACRAAEEFVNVYY | 11 | Q9UKK6 | |
| VQNEDGLYNYRCITR | 186 | O60469 | |
| QLVFQSYEYVDCRGN | 236 | Q96A25 | |
| EQISQERYQYVDCGR | 241 | Q9NUM4 | |
| ERYQYVDCGRNTTYQ | 246 | Q9NUM4 | |
| TCTRFTDEYQLYEDI | 6 | Q13554 | |
| GEDAACIAYIRLTQY | 611 | Q13554 | |
| QDNSSDCGVYLLQYV | 986 | Q9BQF6 | |
| CSQEGNDYFYEIITE | 1646 | O60522 | |
| GCTAYDVAVNSDFYR | 116 | Q9NWS0 | |
| RNLIENDFGVYYCAT | 101 | A0A075B6R0 | |
| ESQYCVLRDFQEYLA | 2516 | Q8WXH0 | |
| FGTVRDCYEALVIYN | 111 | Q9Y519 | |
| ITGLQAEDEADYYCQ | 96 | P01703 | |
| YRSAFYILEQQCVGL | 1361 | A0A087WUL8 | |
| YRSAFYILEQQCVGL | 2581 | A0A087WUL8 | |
| YYEGELQACADVVDR | 746 | Q9HCE1 | |
| QYLDNRDQEGFYCVR | 231 | Q6UWF7 | |
| DTRVYVADNCGLYAQ | 281 | Q9HC36 | |
| VERSQEFDIYTQYCN | 171 | A1L390 | |
| CDYEGQLYEEGVTFL | 196 | Q6ZWJ8 | |
| GVRACYERSNEYQLI | 801 | Q5JWF2 | |
| FTYCDDRIAEVAGYS | 251 | Q9Y2N7 | |
| TVNRCYAVAQEGTYF | 2881 | P25391 | |
| CAFSVIYGENYESLD | 216 | Q9UPR0 | |
| YDFYLISQVACRGTV | 766 | Q7Z3Z4 | |
| QNLIENDSGVYYCAT | 101 | P03979 | |
| SIYSSICGRDDIEYF | 511 | Q86UG4 | |
| RNLIENDSGVYYCAT | 101 | A0A0B4J1U4 | |
| DDGYLCQRGSDIFEY | 2266 | Q9NT68 | |
| FQLCRYGYANTSEVR | 1226 | P14410 | |
| RIQDLDTTDTGYYQC | 121 | Q01974 | |
| EEQDAYYSEVLCFLQ | 176 | Q9BQ13 | |
| DFETIDAGYYICTAQ | 346 | Q15198 | |
| EYRDLTTAGAVTQCY | 96 | Q02543 | |
| YEFGTCEAQVLQLYT | 526 | Q5JTZ9 | |
| SCTDVTEYAVQRNYG | 1841 | Q9H2D6 | |
| NTRQFYDGEESCYII | 1196 | Q15047 | |
| QFDERYTSVAFGYQD | 286 | Q96SE0 | |
| AEEFYVCIYATREGD | 116 | P53396 | |
| YIFLVYAACNEEVRS | 896 | Q7Z7M1 | |
| CGEDFYATSETNYIR | 131 | Q9HAY6 | |
| RGEAETRECIYYNAN | 21 | Q13705 | |
| RQAASEACFYNSDYV | 671 | Q8IZ52 | |
| ECFLRENAYYDSSVV | 891 | P53675 | |
| RQASAEGCFYNADYL | 666 | Q9P2E5 | |
| CNYERYRGLVQNDFA | 111 | Q8N2M8 | |
| GISEEQCLYQIYIDE | 126 | Q8N2M8 | |
| SYEYECSEDGEVFRV | 201 | Q8N9Z0 | |
| QCSFGFIYEREQLEA | 801 | Q96EP0 | |
| NYCEFRGKTYQTLEE | 216 | Q2TAL6 | |
| IDTRATCYEDQGISY | 121 | P00750 | |
| YRLQEFALAAECYEQ | 56 | Q8N4P2 | |
| RIYTRENSYKCEENG | 161 | Q8N7Q3 | |
| QGSDTYIYIFRVCRE | 66 | P20645 | |
| YNANIEDAGIYRCQA | 81 | O15394 | |
| RVENGDQLYQYCSLL | 266 | Q9H5L6 | |
| SRQITQVYGFYDECQ | 116 | O00743 | |
| QEVQITEARCFYGFQ | 151 | P31350 | |
| ETLRFLYGQNYASVC | 381 | Q8IXW5 | |
| NDYLRRQTYGQVVDC | 181 | Q86U17 | |
| RCFQQLDEGYDEEYG | 246 | Q8TB22 | |
| RIDVSINECYDGSYA | 486 | Q15022 | |
| ESARCYALTQSYFEE | 441 | Q9P253 | |
| LQELVDQLYSFRDCY | 16 | Q8N0Z6 | |
| RNLIENDSGVYYCAT | 101 | A0A0C4DH28 | |
| YFCEAQEGSYFREAQ | 611 | O75326 | |
| NFSDCGVYVLQYVES | 1026 | Q9GZR1 | |
| YILEDFNEAQCNTAY | 1786 | Q12888 | |
| QSLTVNDTGEYFCIY | 96 | Q495A1 | |
| SETGQYATYCQRAVE | 951 | Q9ULM0 | |
| EYEVVRDAYGNCVTV | 601 | P27708 | |
| QEYDSGTYRCDVQLV | 151 | Q6P7N7 | |
| EVDYETRQGVYSICL | 1226 | Q9UPU5 | |
| GYAFCEYVDINVTDQ | 301 | P26368 | |
| YRLQEFALAAECYEQ | 56 | Q86WT1 | |
| DDISSNIIGFCYDYL | 341 | O43592 | |
| ENLIERDSGVYYCAT | 101 | A0A0C4DH27 | |
| LIGYSNFQRVEEYCE | 716 | O15041 | |
| LRGNVYVQYQSEEEC | 271 | Q15695 | |
| VREYYSRGQQCLEQA | 61 | Q8NEE8 | |
| QGNYVRETPYEYSEC | 226 | Q8N859 | |
| EVSCQNQEYLFVYGG | 486 | O60294 | |
| SVRYGDFQYCEQAKS | 271 | Q8IWV8 | |
| ESRQITQVYGFYDEC | 116 | P60510 | |
| AAAQNVYCLRTEYIA | 1456 | Q92547 | |
| SLFAFRGQYCYELDE | 171 | P04004 | |
| VVVDGCAYDLDNYQT | 561 | Q05996 | |
| LRGNVYVQYQSEEEC | 266 | Q15696 | |
| NSENTFECYLYGVDF | 101 | Q14584 | |
| QNTACIIYSVEYDFR | 466 | A6NMK8 | |
| CRALYQYVGQDVDEL | 1046 | O00160 | |
| VQVSDSGYYRCVAVN | 641 | Q9NR99 | |
| CTVSDLIVGNEYYFR | 991 | Q14324 |